Cargando…

What is a tumor promoter?

Detalles Bibliográficos
Autor principal:	Tennant, R
Formato:	Texto
Lenguaje:	English
Publicado:	1999
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1566485/ https://www.ncbi.nlm.nih.gov/pubmed/10417370

Ejemplares similares

Tumor Promoters: Tennant's Response
por: Tennant, Raymond
Publicado: (1999)

Comments on "What is a tumor promoter?".
por: Trosko, J E
Publicado: (1999)

Care Coordination for Vulnerable Families in the Sydney Local Health District: What Works for Whom, under What Circumstances, and Why?
por: Eastwood, John G., et al.
Publicado: (2020)

The Tumor Response and Stroma Reaction Following X-ray of a Transplantable Tumor in Inbred Strains of Mice
por: Oughterson, A. W., et al.
Publicado: (1940)

Oral health providers’ views of oral health promotion in Jazan, Saudi Arabia: a qualitative study
por: Shubayr, Mosa Ali, et al.
Publicado: (2023)

What Makes a Potent Nitrosamine? Statistical Validation of Expert-Derived Structure–Activity Relationships
por: Thomas, Robert, et al.
Publicado: (2022)

What promotes sustainability in Safe Community programmes?
por: Nordqvist, Cecilia, et al.
Publicado: (2009)

The Effects of Potassium Deficiency on Tumor-Bearing Mice
por: Liebow, Averill A., et al.
Publicado: (1941)

What’s in a (tumor) cavity?
por: McKay, Michael J.
Publicado: (2020)

A perspective on nonmutagenic mechanisms in carcinogenesis.
por: Tennant, R W
Publicado: (1993)

Contrast-enhanced spectral mammography: what is the 'added value' in a symptomatic setting? Initial findings from a UK centre
por: Tennant, Sarah, et al.
Publicado: (2015)

Mechanism of skin tumorigenesis by contact sensitizers: the effect of the corticosteroid fluocinolone acetonide on inflammation and tumor induction by 2,4 dinitro-1-fluorobenzene in the skin of the TG.AC (v-Ha-ras) mouse.
por: Albert, R E, et al.
Publicado: (1996)

What kind of a gastric tumor is this?
por: RIMBAŞ, M, et al.
Publicado: (2015)

Compassion—A key to innovation: What promotes and what prevents innovation in organizations?
por: Spännäri, Jenni, et al.
Publicado: (2023)

Issues in biochemical applications to risk assessment: are short-term tests predictive of in vivo tumorigenicity?
por: Tennant, R W
Publicado: (1987)

Evaluation and validation issues in the development of transgenic mouse carcinogenicity bioassays.
por: Tennant, R W
Publicado: (1998)

The genetic toxicity database of the National Toxicology Program: evaluation of the relationships between genetic toxicity and carcinogenicity.
por: Tennant, R W
Publicado: (1991)

Potential intakes of total polyols based on UK usage survey data
por: Tennant, David R.
Publicado: (2014)

Chronotype: what role in the context of gastroenteropancreatic neuroendocrine tumors?
por: Barrea, Luigi, et al.
Publicado: (2021)

What to Do To Promote Mental Health of the Society
por: Hajebi, A, et al.
Publicado: (2013)

Workplace policies and practices promoting physical activity across England: What is commonly used and what works?
por: Knox, Emily Caitlin Lily, et al.
Publicado: (2017)

The preservation of bidirectional promoter architecture in eukaryotes: what is the driving force?
por: Xu, Chao, et al.
Publicado: (2012)

Factors affecting mammary tumor incidence in chlorotriazine-treated female rats: hormonal properties, dosage, and animal strain.
por: Eldridge, J C, et al.
Publicado: (1994)

Circulating tumor cell clusters: What we know and what we expect (Review)
por: Hong, Yupeng, et al.
Publicado: (2016)

Tumor Necrosis Factor: What Is in a Name?
por: Wang, Xinming, et al.
Publicado: (2022)

Engineering amino acid uptake or catabolism promotes CAR T-cell adaption to the tumor environment
por: Panetti, Silvia, et al.
Publicado: (2022)

Acceptance of interventions to promote primary care: What do physicians prioritize?
por: Tandjung, Ryan, et al.
Publicado: (2015)

Cell Lines of Circulating Tumor Cells: What Is Known and What Needs to Be Resolved
por: Shimada, Yutaka, et al.
Publicado: (2022)

Admission to hospital following head injury in England: Incidence and socio-economic associations
por: Tennant, Alan
Publicado: (2005)

What are the barriers and facilitators to effective health promotion in urgent and emergency care? A systematic review
por: Schofield, B., et al.
Publicado: (2022)

Genetic toxicology: current status of methods of carcinogen identification.
por: Tennant, R W, et al.
Publicado: (1993)

Predictions for the outcome of rodent carcinogenicity bioassays: identification of trans-species carcinogens and noncarcinogens.
por: Tennant, R W, et al.
Publicado: (1996)

Uncertainty promotes information-seeking actions, but what information?
por: Keller, Ashlynn M., et al.
Publicado: (2020)

Patient participation in multidisciplinary tumor conferences: How is it implemented? What is the patients’ role? What are patients’ experiences?
por: Ansmann, Lena, et al.
Publicado: (2021)

What You See Is Not What You Get: Germ Cell Tumor Mimicking Disseminated Coccidioidomycosis
por: Hajeh, Haidar, et al.
Publicado: (2023)

Transformative health promotion: what is needed to advance progress?
por: Barry, Margaret M.
Publicado: (2021)

Promotion of lung tumors in mice.
por: Witschi, H P
Publicado: (1983)

Tumor promotion in rat liver.
por: Herren, S L, et al.
Publicado: (1983)

Net Promoter Score (NPS): What Does Net Promoter Score Offer in the Evaluation of Continuing Medical Education?
por: Lucero, Katie Stringer
Publicado: (2022)

Promoting equality for ethnic minority NHS staff—what works?
por: Priest, Naomi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_432rdgb5bvqvncb3hh21bmoinb